AI reads CT scans to predict stomach Cancer's return
NCT ID NCT07683195
First seen Jul 06, 2026 · Last updated Jul 08, 2026 · Updated 2 times
Summary
This study explores whether artificial intelligence can predict if stomach cancer will come back within a year after surgery. Researchers will analyze CT scans and clinical data from 900 patients with locally advanced gastric cancer. The goal is to build a model that helps doctors identify high-risk patients earlier.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this AI model could help doctors identify patients at high risk of cancer returning soon after surgery, allowing for closer monitoring or earlier treatment.
- What could go wrong
- This is an observational study using existing data, not a treatment trial. The AI model may not be accurate enough for real-world use, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
QianfoshanH
Jinan, Shandong, 250014, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Three-Drug cocktail shrink stomach tumors before surgery?
- Can a new nucleotide analogue boost cancer treatment?
- Can a less extensive stomach surgery preserve appetite better?
- Can a vaccine stop stomach cancer from coming back?
- New imaging compound targets Hard-to-Spot cancers
- Experimental pill SHY-ONC6 takes on Hard-to-Treat cancers